{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:33:23Z","timestamp":1793414003644,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.esmoop.2021.100262","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T12:19:13Z","timestamp":1630671553000},"page":"100262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Immune checkpoint inhibitor administration during pregnancy: a case series"],"prefix":"10.1016","volume":"6","author":[{"given":"A.","family":"Andrikopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Korakiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Apostolidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Zagouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.esmoop.2021.100262_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13045-018-0578-4","article-title":"Lessons learned from the blockade of immune checkpoints in cancer immunotherapy","volume":"11","author":"Li","year":"2018","journal-title":"J\u00a0Hematol Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2021.100262_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s13046-019-1259-z","article-title":"Combination of CTLA-4 and PD-1 blockers for treatment of cancer","volume":"38","author":"Rotte","year":"2019","journal-title":"J\u00a0Exp Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.esmoop.2021.100262_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1470-2045(18)30059-7","article-title":"Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients","volume":"19","author":"de Haan","year":"2018","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.esmoop.2021.100262_bib4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1634\/theoncologist.2002-0279","article-title":"Coexistence of pregnancy and malignancy","volume":"7","author":"Pavlidis","year":"2002","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.esmoop.2021.100262_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1470-2045(04)01466-4","article-title":"Use of chemotherapy during human pregnancy","volume":"5","author":"Cardonick","year":"2004","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.esmoop.2021.100262_bib6","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1200\/JCO.2009.23.2801","article-title":"Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes","volume":"28","author":"Van Calsteren","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.esmoop.2021.100262_bib10","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.annonc.2021.03.199","article-title":"Immunotherapy use outside clinical trial populations: never say never?","volume":"32","author":"Rzeniewicz","year":"2021","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2021.100262_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.14740\/wjon1177","article-title":"Cancer during pregnancy: the oncologist overview","volume":"10","author":"Hepner","year":"2019","journal-title":"World J Oncol"},{"issue":"11","key":"10.1016\/j.esmoop.2021.100262_bib12","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/cncr.30642","article-title":"Immune checkpoint inhibitors in challenging populations","volume":"123","author":"Johnson","year":"2017","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.esmoop.2021.100262_bib13","first-page":"752","volume":"54","author":"Benardete-Harari","year":"2016","journal-title":"Rev Med Inst Mex Seguro Soc"},{"issue":"4","key":"10.1016\/j.esmoop.2021.100262_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1055\/s-2000-10214","article-title":"Malignant melanoma and pregnancy","volume":"204","author":"Karbowski","year":"2000","journal-title":"Z\u00a0Geburtshilfe Neonatol"},{"issue":"6","key":"10.1016\/j.esmoop.2021.100262_bib15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3390\/medicina44060061","article-title":"Metastatic amelanotic nodular melanoma during pregnancy","volume":"44","author":"Jasaitiene","year":"2008","journal-title":"Medicina (Kaunas)"},{"issue":"5","key":"10.1016\/j.esmoop.2021.100262_bib16","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/IGC.0b013e3181daaf3e","article-title":"Malignancies diagnosed during pregnancy and treated with chemotherapy or other modalities (review of 27 cases)","volume":"20","author":"Ustaalioglu","year":"2010","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"10.1016\/j.esmoop.2021.100262_bib17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1610-0387.2006.06055.x","article-title":"Diagnostische und therapeutische ma\u00dfnahmen in der behandlung des malignen melanoms w\u00e4hrend der schwangerschaft: Risiko f\u00fcr den fetus? Fallbericht und literatur-\u00fcberblick","volume":"4","author":"Egberts","year":"2006","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"issue":"12","key":"10.1016\/j.esmoop.2021.100262_bib18","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1159\/000251841","article-title":"Advanced metastatic melanoma during pregnancy: a multidisciplinary challenge","volume":"32","author":"Gottschalk","year":"2009","journal-title":"Onkologie"},{"issue":"6","key":"10.1016\/j.esmoop.2021.100262_bib19","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.annonc.2020.02.015","article-title":"Successful pregnancy in a cancer patient previously cured of a gestational trophoblastic tumor by immunotherapy","volume":"31","author":"Bolze","year":"2020","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2021.100262_bib20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-0038-1624578","article-title":"Postpartum genital melanoma - a case report","volume":"40","author":"Nai","year":"2018","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"5","key":"10.1016\/j.esmoop.2021.100262_bib21","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.pulmoe.2020.05.004","article-title":"Treatment of lung cancer during pregnancy","volume":"26","author":"Soares","year":"2020","journal-title":"Pulmonology"},{"issue":"3","key":"10.1016\/j.esmoop.2021.100262_bib22","first-page":"232","article-title":"A\u00a033 year old pregnant women with an adenoneuroendocrine carcinoma (MANEC) of the cervix uteri","volume":"40","author":"Erdmann","year":"2017","journal-title":"Oncol Res Treat"},{"issue":"2","key":"10.1016\/j.esmoop.2021.100262_bib23","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ctrv.2009.11.004","article-title":"Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: hematological tumors","volume":"36","author":"Azim","year":"2010","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"10.1016\/j.esmoop.2021.100262_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ctrv.2009.11.007","article-title":"Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: solid tumors","volume":"36","author":"Azim","year":"2010","journal-title":"Cancer Treat Rev"},{"issue":"12","key":"10.1016\/j.esmoop.2021.100262_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12123616","article-title":"Update on the management of breast cancer during pregnancy","volume":"12","author":"Poggio","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.esmoop.2021.100262_bib26","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1053\/j.seminoncol.2018.03.005","article-title":"A\u00a0comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy","volume":"45","author":"Flint","year":"2018","journal-title":"Semin Oncol"},{"issue":"4","key":"10.1016\/j.esmoop.2021.100262_bib27","first-page":"277","article-title":"Neue dermatologische systemtherapien bei kinderwunsch, schwangerschaft und stillzeit","volume":"13","author":"Grunewald","year":"2015","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"issue":"2","key":"10.1016\/j.esmoop.2021.100262_bib28","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/bdrb.21176","article-title":"An evaluation of the impact of PD-1 pathway blockade on reproductive safety of therapeutic PD-1 inhibitors","volume":"107","author":"Poulet","year":"2016","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"10.1016\/j.esmoop.2021.100262_bib29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejca.2018.09.008","article-title":"Immunotherapy with ipilimumab plus nivolumab in a stage IV melanoma patient during pregnancy","volume":"104","author":"Menzer","year":"2018","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.esmoop.2021.100262_bib30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/CMR.0000000000000657","article-title":"Conception and viable twin pregnancy in a patient with metastatic melanoma while treated with CTLA-4 and PD-1 checkpoint inhibition","volume":"30","author":"Bucheit","year":"2020","journal-title":"Melanoma Res"},{"issue":"3","key":"10.1016\/j.esmoop.2021.100262_bib31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/CMR.0000000000000586","article-title":"Pregnancy with successful foetal and maternal outcome in a melanoma patient treated with nivolumab in the first trimester: case report and review of the literature","volume":"29","author":"Xu","year":"2019","journal-title":"Melanoma Res"},{"issue":"3","key":"10.1016\/j.esmoop.2021.100262_bib32","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/j.seminoncol.2018.03.003","article-title":"Viable pregnancy in a patient with metastatic melanoma treated with double checkpoint immunotherapy","volume":"45","author":"Burotto","year":"2018","journal-title":"Semin Oncol"},{"key":"10.1016\/j.esmoop.2021.100262_bib33","first-page":"1","article-title":"Case report of a pregnancy during ipilimumab therapy","volume":"4","author":"Mehta","year":"2018","journal-title":"J\u00a0Glob Oncol"},{"issue":"5","key":"10.1016\/j.esmoop.2021.100262_bib34","first-page":"762","article-title":"Pregnancy in a patient with metastatic uveal melanoma treated with nivolumab","volume":"19","author":"Haiduk","year":"2021","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.esmoop.2021.100262_bib36","doi-asserted-by":"crossref","unstructured":"Niemi A, Foeller ME, Yeaton-Massey A, Fan AC, Winn VD, Hintz SR. Preterm birth after treatment of maternal metastatic melanoma with immunotherapeutics. In: Western Medical Research Conference 2017 (Formerly Western Regional Meeting) Camel, California, January 26\u201328, 2017. Journal of Investigative Medicine; 2017. Available at https:\/\/jim.bmj.com\/content\/65\/1\/254. Accessed May 14,\u00a02021.","DOI":"10.1136\/jim-2016-000365.369"},{"key":"10.1016\/j.esmoop.2021.100262_bib37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejogrb.2017.04.023","article-title":"Maternal and perinatal outcomes in pregnancy-associated melanoma. Report of two cases and a systematic literature review","volume":"214","author":"Mendiz\u00e1bal","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.esmoop.2021.100262_bib38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1084\/jem.20050019","article-title":"A\u00a0critical role for the programmed death ligand 1 in fetomaternal tolerance","volume":"202","author":"Guleria","year":"2005","journal-title":"J\u00a0Exp Med"},{"issue":"1","key":"10.1016\/j.esmoop.2021.100262_bib39","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/molehr\/5.1.84","article-title":"The CTLA-4 gene is expressed in placental fibroblasts","volume":"5","author":"Kaufman","year":"1999","journal-title":"Mol Hum Reprod"},{"issue":"1","key":"10.1016\/j.esmoop.2021.100262_bib40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1158\/2326-6066.CIR-13-0013","article-title":"Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells","volume":"1","author":"Selby","year":"2013","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"10.1016\/j.esmoop.2021.100262_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13061440","article-title":"CTLA-4 in regulatory T cells for cancer immunotherapy","volume":"13","author":"Sobhani","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.esmoop.2021.100262_bib42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.17925\/USE.2020.16.2.117","article-title":"An update on immune checkpoint inhibitor-related hypophysitis","volume":"16","author":"Mortensen","year":"2020","journal-title":"US Endocrinol"},{"issue":"12","key":"10.1016\/j.esmoop.2021.100262_bib43","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJMoa071453","article-title":"Long-term outcomes after repeat doses of antenatal corticosteroids","volume":"357","author":"Wapner","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.esmoop.2021.100262_bib44","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1097\/AOG.0000000000002237","article-title":"Committee Opinion No. 713: antenatal corticosteroid therapy for fetal maturation","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.esmoop.2021.100262_bib45","doi-asserted-by":"crossref","first-page":"i5044","DOI":"10.1136\/bmj.i5044","article-title":"Antenatal corticosteroids for maturity of term or near term fetuses: systematic review and meta-analysis of randomized controlled trials","volume":"355","author":"Saccone","year":"2016","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.esmoop.2021.100262_bib47","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/bdrb.20201","article-title":"An interspecies comparison of placental antibody transfer: new insights into developmental toxicity testing of monoclonal antibodies","volume":"86","author":"Pent\u0161uk","year":"2009","journal-title":"Birth Defects Res B Dev Reprod Toxicol"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702921002246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702921002246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:27:57Z","timestamp":1761856077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702921002246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2059702921002246"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2021.100262","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune checkpoint inhibitor administration during pregnancy: a case series","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2021.100262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100262"}}